Erythropoietin treatment found to be ineffective for newborns with low oxygen or blood supply

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The research was presented at the Pediatric Academic Societies (PAS) 2025 Meeting, held April 24–28 in Honolulu.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup